Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 33 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1300. Clear
Clear
Q1
THEGROUP DC, LLC for ASTELLAS PHARMA US, INC
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $70,000.00 income
Health Issues, Pharmacy
View →
Q1
ASTELLAS PHARMA US, INC. for ASTELLAS PHARMA US, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate
Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark, Taxation/Internal Revenue Code
View →
Q1
DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q1
AMERICAN ASSOCIATION OF NURSE PRACTITIONERS for AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate
Health Issues, Budget/Appropriations, Government Issues, Medicare/Medicaid
View →
Q1
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Indian/Native American Affairs, Taxation/Internal Revenue Code, Tobacco
View →
Q1
ZERO PROSTATE CANCER for ZERO PROSTATE CANCER
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate
Budget/Appropriations, Health Issues, Insurance, Veterans
View →
4A
DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate
Medical/Disease Research/Clinical Labs, Tobacco, Health Issues, Medicare/Medicaid
View →
Q4
THEGROUP DC, LLC for ASTELLAS PHARMA US, INC
4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate · $70,000.00 income
Health Issues, Pharmacy
View →
Q4
DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q4
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Taxation/Internal Revenue Code, Tobacco, Budget/Appropriations
View →
Q4
AMERICAN ASSOCIATION OF NURSE PRACTITIONERS for AMERICAN ASSOCIATION OF NURSE PRACTITIONERS
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate
Health Issues, Education, Budget/Appropriations, Government Issues
View →
Q4
ASTELLAS PHARMA US, INC. for ASTELLAS PHARMA US, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate
Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark, Taxation/Internal Revenue Code
View →
Q4
ZERO PROSTATE CANCER for ZERO PROSTATE CANCER
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate
Budget/Appropriations, Health Issues, Insurance, Veterans
View →
4T
VENABLE LLP for AMERICAN UROLOGICAL ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $30,000.00 income
Budget/Appropriations, Health Issues
View →
Q3
THEGROUP DC, LLC for ASTELLAS PHARMA US, INC
3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate · $70,000.00 income
Health Issues, Pharmacy
View →
Q3
DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Q3
ASTELLAS PHARMA US, INC. for ASTELLAS PHARMA US, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate
Taxation/Internal Revenue Code, Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark
View →
Q3
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Health Issues, Taxation/Internal Revenue Code, Tobacco, Budget/Appropriations
View →
Q3
ZERO PROSTATE CANCER for ZERO PROSTATE CANCER
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate
Budget/Appropriations, Health Issues, Insurance, Veterans
View →
Q3
VENABLE LLP for AMERICAN UROLOGICAL ASSOCIATION
3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate · $30,000.00 income
Budget/Appropriations, Health Issues
View →
Q2
THEGROUP DC, LLC for ASTELLAS PHARMA US, INC
2nd Quarter (Apr 1 - June 30) 2025 · Illinois · House · Senate · $70,000.00 income
Health Issues, Pharmacy
View →
Q2
THE MCMANUS GROUP for DENDREON PHARMACEUTICALS LLC
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
ASTELLAS PHARMA US, INC. for ASTELLAS PHARMA US, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Illinois · House · Senate
Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark, Taxation/Internal Revenue Code
View →
Q2
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Taxation/Internal Revenue Code, Tobacco, Budget/Appropriations
View →
Q2
DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs
View →
Page 1 of 2 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem